FundraiseBase by

Soleus Capital

2 rounds tracked since 8 January 2026.

Rounds: 2
Led: 0
Capital in these rounds: $435M

Sectors

Health2

Countries

Not disclosed2

Rounds

Crystalys TherapeuticsBiopharmaceutical company advancing dotinurad through global Phase 3 development for gout treatment. $130MSeries B · 22 Jul
Parabilis MedicinesDevelops oncology therapies, including FOG-001 (zolucatetide), using its Helicon platform. $305M8 Jan

Often invests with

The Daily Raise

The day's rounds in your inbox each morning.

Subscribe to The Daily Raise